Multiple award BPA; modernizing FDA data and analytics next phase solutions & services see also 75F40124A00008; 75F40124A00009; 75F40124A00010; 75F40124A00012

Ended Awarded Last action

Contract number
75F40124A00011
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 75F40123Q00038 Solicitation number
Last date to order 100% complete
IDV ceiling
$500,000,000.00
Maximum order
$500,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 23 offers Multiple Award, Fair Opportunity
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The Food and Drug Administration (FDA) awarded a multiple-award Blanket Purchase Agreement (BPA) to Next Phase Solutions and Services, Inc. (UEI: GF3NMJ8FFSC1), a woman-owned small business headquartered in Columbia, Maryland, with a ceiling value of $500 million. The BPA, effective August 26, 2024, through May 5, 2025, supports the FDA's modernization of data and analytics capabilities through next-phase solutions and services. Next Phase Solutions and Services holds Small Business Administration (SBA) certifications as an Economically Disadvantaged Women-Owned Small Business (EDWOSB), an 8(a) Program Participant (expiring September 13, 2026), and a Women-Owned Small Business (WOSB), positioning the awardee within the applicable set-aside programs. As a prime contractor, Next Phase Solutions and Services will deliver comprehensive information technology, data management, and business analytics services designed to enhance the FDA's enterprise data capabilities and analytical infrastructure.

This BPA is part of a larger multiple-award vehicle under the Modernizing FDA Data and Analytics initiative, with related awards to other contractors (75F40124A00008, 75F40124A00009, 75F40124A00010, and 75F40124A00012). The contract aligns with the HHS Cost Efficiency Initiative and leverages Next Phase Solutions and Services' demonstrated expertise in enterprise master data management, enterprise data lake services, business analytics, and information technology support. The scope encompasses technical and engineering solutions, management and advisory services, and research and development activities necessary to modernize the FDA's data infrastructure and analytics capabilities, supporting the agency's mission to protect public health through improved data-driven decision-making and operational efficiency.

Transactions

Action Obligated Date
Terminate for Convenience P00002 $0
Terminate for Convenience P00001 · EOI:: HHS cost efficiency initiative:: EOI termination for convenience agreement multiple award BPA; modernizing FDA data and analytics next phase solutions &… $0
Original award $0

Quick answers

Who was awarded contract 75F40124A00011?

75F40124A00011 was awarded to Next Phase Solutions And Services, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 26, 2024.

How much is contract 75F40124A00011 worth?

75F40124A00011's own ceiling is $500,000,000. A single order can be worth up to $500,000,000.

Who can order from contract 75F40124A00011?

75F40124A00011 is a multiple award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 75F40124A00011 under another contract?

Yes. 75F40124A00011 is a blanket purchase agreement under GS35F498CA, a federal supply schedule, on Modernizing FDA Data and Analytics.

Was contract 75F40124A00011 competed?

The extent of competition for 75F40124A00011 was full and open competition. The government received 23 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV